Scoping a Compulsory Licensing Strategy for Countries Excluded from Gilead’s Long-Acting Lenacapavir Voluntary Licenses

February 18, 2025 | Access to Medicines

Scoping a Compulsory Licensing Strategy for Countries Excluded from Gilead’s Long-Acting Lenacapavir Voluntary Licenses

Get PDF